Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. - Wikidata - wikimedia - TriplyDB

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

http://www.wikidata.org/entity/Q36181155

about

Viral Evasion of Natural Killer Cell Activation NK Cells in HIV Disease Human NK Cell Diversity in Viral Infection: Ramifications of Ramification Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Newtonian cell interactions shape natural killer cell education Natural Killer Cells--An Epigenetic Perspective of Development and Regulation Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation Features of Memory-Like and PD-1(+) Human NK Cell Subsets 'Trained immunity': consequences for lymphoid malignancies Harnessing adaptive natural killer cells in cancer immunotherapy Boosting vaccine efficacy the natural (killer) way Memory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis Antigens Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.Hepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.Natural Killer Cells in Viral Hepatitis.The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk.Antigen-specific NK cell memory in rhesus macaques.Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients Natural Killer Cell Memory.CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.Roles of natural killer cells in antiviral immunity Human Cytokine-Induced Memory-Like Natural Killer Cells.Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.The DNA methylation profile of activated human natural killer cells.NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.Harnessing the beneficial heterologous effects of vaccination.Natural Killer Cell Diversity in Viral Infection: Why and How Much?Cognate HLA absence in trans diminishes human NK cell education.Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection Calorie Restriction Attenuates Terminal Differentiation of Immune Cells.A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART.NK Cells: Uncertain Allies against Malaria.Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression Orphan NKs! The mystery of the self-renewing NK cells.Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Selection, tuning, and adaptation in mouse NK cell education.

P2860

Q26748421-449078EB-D3EA-4C6E-A022-9C65E01A3E49 Q26752833-0A47A0A9-D4A2-41AC-A5DE-3D6F6D2B7332 Q26765925-D0C25069-1BAF-4C4E-95A4-079829F2F3D2 Q26776114-AE901379-DBA4-45F3-AA2A-8AAA464FF18A Q26797240-7407B25B-6187-43DE-91C5-D1D7FD24D276 Q26825095-5A9C010D-117E-44B7-931A-D42EE467E973 Q28067993-25CBA918-BB8E-48B9-8201-B5CCD8DB355A Q28069456-08F65078-27EA-4065-8061-BA224D8AACEA Q28069682-69B342B3-D5BE-445D-9034-03BD90FB3A5C Q28073988-25AD938A-3CC9-409F-8F3F-95AE9749F1F3 Q28074639-968BFA15-BF00-4CF4-90FE-762A22AA250A Q28081448-160AFEF5-CA8E-4A34-8DD3-5BEE09F16A93 Q28084474-59C004AF-1EFC-49D9-A56D-58C7F883A0DD Q28391029-67042ED5-6E3C-486C-9FE7-1BA0973C8D84 Q33646189-1500569C-4389-45EF-9549-88709A912430 Q33694920-81329AA5-F63D-4669-92B0-1A9129843E51 Q34505690-610943E0-55F2-419C-AC3F-BAED81E5F948 Q34549025-1A814F07-1102-41E6-B7AA-7E3C7E7B54DC Q35984239-1AD89F91-B959-4DAB-A8D4-EBA4B72D7B50 Q36123419-8439C51A-B6CD-4FAD-942D-2C6F42523B32 Q36211144-EBA3FE5E-7789-4918-B192-4C18434BDB23 Q36540532-62057F8F-DFF2-42BF-A1C6-6C9B8C5316D7 Q36750477-09D0417C-F6CD-48E8-AC03-2CCF00D34C1D Q36767761-37BCF06E-7B4F-456F-A2ED-A98F987ACD70 Q36830628-93C76CB9-1276-42DE-BBD3-149D207CE676 Q36874773-83F811D1-C5EE-4C8A-8CD7-CA6996787330 Q36956985-E83A3EA0-2C59-4640-8179-8875E660D961 Q36995079-D16554A9-C9ED-47DC-B1B2-FD7F90A6CAF6 Q37061098-C5A4ACE0-3E00-42D3-B684-6D9A70683FA5 Q37252674-A1D7C219-25EA-4B50-BBD3-B45A69DB7514 Q37395734-DF304B47-2B4D-46A7-BB90-4B3B91792402 Q37574331-3CF09ED3-8D6A-4F68-A950-BE1A09853530 Q37580813-BBED0527-AA35-438A-891C-8061EE2C4ACB Q37634635-152C08BE-7EE3-436D-9DEE-D58121CC8E28 Q37689434-2E075195-C630-412D-B1C2-135FDB6D5C32 Q37727470-7BFF59CA-C7FC-4A3F-AF47-3934F177F294 Q37740863-65A86EF0-0ED1-420C-B031-9168F3BE5666 Q37741570-69589811-F5C8-447F-9968-0EF4C30FF9AA Q38513534-82BCC87C-980A-48F4-A53A-B4E62BD727DF Q38568877-31D73B94-B755-4160-ADA8-8FF70B678067

P2860

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

http://www.wikidata.org/entity/Q36181155

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cytomegalovirus infection driv ...... gnaling and effector function.

@ast

Cytomegalovirus infection driv ...... gnaling and effector function.

@en

type

label

Cytomegalovirus infection driv ...... gnaling and effector function.

@ast

Cytomegalovirus infection driv ...... gnaling and effector function.

@en

prefLabel

Cytomegalovirus infection driv ...... gnaling and effector function.

@ast

Cytomegalovirus infection driv ...... gnaling and effector function.

@en

P1433

Q36181155-9F317648-9761-4EC3-893C-721FF5F9BBF5

P1476

Q36181155-C53B907B-B04D-4C02-9EFD-1AEBD914453C

P2093

Q36181155-0CA200AC-A191-4454-B3F2-527BB53EC841

Q36181155-34B948ED-F55A-4577-9481-BCE8EFF6CCA4

Q36181155-3CDAB6D5-AA72-4B35-8AE9-068BA11FEB49

Q36181155-4DD9F717-AE0D-42CD-AA42-52DC3F305151

Q36181155-4FE58DE9-F48C-44F7-AFA1-7B24879E6F49

Q36181155-55041505-38C3-4990-9A10-A2B8F315C98B

Q36181155-85C88979-FCD2-4FC6-B2D3-08F44C737631

Q36181155-89D06109-8C73-4AF5-A0E0-884407ECF2D2

Q36181155-AB139CDA-29B8-4DE2-A44F-72870C555CE3

Q36181155-DC42451F-3B42-4716-908D-DE6407A05C2A

P2860

Q36181155-0B7B2165-C075-4036-AC7E-88CFA4C0F5CA

Q36181155-13A3F422-D3D9-42E7-9868-8D184DBBF007

Q36181155-1963408A-6DDA-4DBE-8EE6-04446F3EAF2D

Q36181155-1D6D56E3-BAF3-4C8E-8D0F-5688B9B8C920

Q36181155-31A3DA48-FCF0-40C6-9AE9-20F8E58FFB82

Q36181155-36920963-07F5-424B-9CE0-BBFA3F8E49A6

Q36181155-422BA239-742F-4811-9A69-3BD2DDC2ABC5

Q36181155-4631F1BA-F653-4733-85D8-60C9184E6628

Q36181155-4651AB7C-5BCB-4F9A-B8B2-D67B84DE5696

Q36181155-47ACEE36-78C2-4BE1-81E2-1C80AE1D3F85

P304

Q36181155-592BFB8C-A9D8-4560-8392-C4801509DF2F

P31

Q36181155-52A476CD-8D74-499D-B206-EBC793B986BD

P356

Q36181155-6001288B-A0A8-47E2-B810-8B705D912CB4

P407

Q36181155-C42C6819-EB93-48D4-823C-EF6EF616546E

P433

Q36181155-29E2FEFB-6A70-4AA5-8D4B-ECE6238FD881

P478

Q36181155-FD989D91-CC6F-44C8-AFFA-EE5CB77D12C1

P50

Q36181155-056D1579-56C4-449C-8D13-4551A5DFFC51

Q36181155-1FC5948A-9F79-4E8C-9530-6CC7684DFC27

Q36181155-2C70BC81-FEE5-4AA1-A40A-1A4801731C36

Q36181155-6F30F6FE-85B6-4FFF-BE1F-7404F6053811

Q36181155-73D45B09-54E2-4D75-BEA0-77763FA57E62

Q36181155-C0FE541F-0C64-4829-A7DF-B46B99CFAD7D

P577

Q36181155-BAAC11E0-FF6A-4CA7-8C62-0DF8451E4256

P698

Q36181155-112662EC-18E9-41AC-BAF4-64EFC684BB01

P921

Q36181155-51CBA261-6ACB-4DE2-B957-89A0BB385C45

P932

Q36181155-9D1DE08F-B08A-4314-9DA9-338455431870

P356

J.IMMUNI.2015.02.008

P1433

P1476

Cytomegalovirus infection driv ...... gnaling and effector function.

@en

P2093

Bree Foley

http://www.w3.org/2001/XMLSchema#string

Frank Cichocki

http://www.w3.org/2001/XMLSchema#string

Hans-Gustaf Ljunggren

http://www.w3.org/2001/XMLSchema#string

Heinrich Schlums

http://www.w3.org/2001/XMLSchema#string

Hongya Han

http://www.w3.org/2001/XMLSchema#string

Jakob Theorell

http://www.w3.org/2001/XMLSchema#string

Kristin Mattsson

http://www.w3.org/2001/XMLSchema#string

Marie Schaffer

http://www.w3.org/2001/XMLSchema#string

Stella Larsson

http://www.w3.org/2001/XMLSchema#string

Tim D Holmes

http://www.w3.org/2001/XMLSchema#string

P2860

TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity

The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions

The transcription factor PLZF directs the effector program of the NKT cell lineage

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

Innate or adaptive immunity? The example of natural killer cells

Signal transduction by lymphocyte antigen receptors

Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans.

Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient.

Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases

P304

443-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2015.02.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Yenan T Bryceson

Jeffrey S. Miller

Karl-Johan Malmberg

Samuel C Chiang

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25786176

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

4612277

http://www.w3.org/2001/XMLSchema#string